MDSpire - MDSpire Home
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

MDSpire News

  • September 23, 2026
Female patients less likely to receive invasive care
  • Andrea Surnit
  • September 23, 2026
  • 5 min

Objective: To examine sex-based differences in patient management across medical specialties, particularly the likelihood of receiving invasive or intensive tre

...more
2 min

Baptist Health South Florida

  • September 23, 2026
Matthew David Hall, M.D., MBA, Installed as Endowed Chair in Pediatric Oncology at Baptist Health Herbert Wertheim Cancer Institute
  • September 23, 2026
  • 3 min
  1. Matthew D. Hall, M.D., MBA, was installed as the Endowed Chair in Pediatric Radiation Oncology at Baptist Health Herbert Wertheim Cancer Institute.
  2. The endowed chair was established through philanthropic support to advance Dr. Hall's research on reducing long-term side effects of radiation therapy in children.
  3. Dr. Hall is recognized for his expertise in proton therapy, which minimizes radiation exposure to healthy tissues in pediatric patients.
  4. Since 2016, Dr. Hall has led the growth of Florida's largest pediatric radiation oncology program at the Wertheim Cancer Institute.
  5. In 2024, Dr. Hall was elected president of the Particle Therapy Cooperative Group of North America.
...more

Baptist Health South Florida

  • September 23, 2026
Aurelio B. Castrellon, M.D., Joins The Eugene M. and Christine E. Lynn Cancer Institute as a Medical Oncologist
  • September 23, 2026
  • 2 min

Get a structured, in-depth report that distills clinical articles into clear insights, data, and analysis for deeper learning.

Read Full Report

Baptist Health South Florida

  • September 23, 2026
Kfir Ben-David, M.D., FACS, Joins The Eugene M. and Christine E. Lynn Cancer Institute as a Surgical Oncologist
  • September 23, 2026
  • 3 min
  1. Kfir Ben-David, M.D., FACS, has joined the Eugene M. and Christine E. Lynn Cancer Institute as a surgical oncologist.
  2. He specializes in complex minimally invasive gastrointestinal surgery and has interests in various types of cancer.
  3. Dr. Ben-David serves as chair of the Department of Surgery at Florida Atlantic University and is a fellow of the American College of Surgeons.
  4. He has authored over 100 peer-reviewed publications and has extensive experience in minimally invasive esophageal surgery.
  5. Dr. Ben-David emphasizes a patient-centered approach, prioritizing compassion, transparency, and shared decision-making.
...more

Inside Dentistry

  • September 23, 2026
Google Review Policy Changes Affect Dental Practice Solicitation Strategies
  • News Staff
  • September 23, 2026
  • 3 min

Objective: To inform dental practices about changes in Google's review solicitation policies and their implications. Approach: Policy Changes: Google's April 20

...more

Inside Dentistry

  • September 23, 2026
DEXIS Announces Updates Across Dental Imaging Portfolio
  • News Staff
  • September 23, 2026
  • 3 min

Objective: To inform about the latest updates and innovations in DEXIS's dental imaging portfolio. Approach: Imaging Hardware: Introduction of the NOMAD™ Pro 3

...more

Inside Dentistry

  • September 23, 2026
Cloud Dentistry Survey Examines Staffing Challenges and Flexible Work
  • News Staff
  • September 23, 2026
  • 2 min

Objective: To explore hiring challenges and attitudes toward flexible staffing among dental professionals and organizations. Approach: Survey Participants: 1,31

...more
1 min

MDSpire News

  • September 23, 2026
Muscle recovery following knee arthroplasty
  • Kathryn Wighton
  • September 23, 2026
  • 3 min

Objective: To evaluate quadriceps and hamstring strength and flexibility changes following total knee arthroplasty over a 12-month period. Approach: Study Desig

...more

The Pathologist

  • September 23, 2026
Can Drying Drive TB Drug Resistance?
  • September 23, 2026
  • 3 min
  1. Desiccation caused DNA damage in Mycobacterium tuberculosis, increasing the frequency of rifampin-resistant bacteria in laboratory tests.
  2. The study developed a filter-based system to simulate drying during aerosol formation, affecting bacterial genetic diversity.
  3. Desiccated bacteria showed rifampin-resistant colonies at a frequency 50 to 100 times higher than those maintained in saline.
  4. Silencing the mfd gene reduced rifampin resistance frequency and altered mutations in rpoB, impacting survival during drying.
  5. The study emphasizes the need to recognize multiple resistance-associated alleles and investigate genotype-phenotype discordance.
...more

The Pathologist

  • September 23, 2026
From Patient to Problem Solver
  • Helen Bristow
  • September 23, 2026
  • 10 min
  1. Luis Cano's childhood experience as an oncology patient in Peru inspired his career in medicine and shaped his perspective on patient care.
  2. Cano's family faced significant challenges accessing healthcare, highlighting the complexities of navigating the medical system.
  3. His medical training in Chimbote exposed him to diverse cases and reinforced his understanding of the physician's responsibility.
  4. Cano's curiosity about how the body works led him to pathology, where he enjoys uncovering the stories behind disease.
  5. He emphasizes the importance of asking the right questions in problem-solving, acknowledging the subjective nature of interpretation.
...more

The Analytical Scientist

  • September 23, 2026
Musings from The Power List: Bob Pirok
  • September 23, 2026
  • 9 min
  1. Bob Pirok develops analytical solutions using chromatography to address societal and industrial challenges.
  2. He emphasizes the importance of autonomous laboratories and AI in enhancing analytical workflows and accessibility.
  3. Pirok identifies defining analytical objectives as a central challenge in analytical science today.
  4. He argues that bias in analytical science can distort answers and mislead future systems.
  5. Pirok believes AI can help clarify analytical questions but should not replace the role of the analyst.
...more

The Medicine Maker

  • September 23, 2026
“Plug-and-Play” CAR T Platform Enables Post-Infusion Retargeting
  • September 23, 2026
  • 3 min
  1. The modular CAR T-cell platform allows post-infusion modification of engineered immune cells' behavior and targeting.
  2. The meCAR developed at City of Hope features a docking site for protein adaptors, enhancing CAR T-cell functionality.
  3. In preclinical studies, meCAR T cells showed comparable tumor-cell killing to conventional CAR T cells.
  4. Combining adaptors with meCAR T cells improved T-cell expansion and reduced tumor burden in mouse models.
  5. The platform's flexibility allows for the addition of new capabilities to CAR T cells as needed, but dosing must be optimized.
...more

The Medicine Maker

  • September 23, 2026
Advanced Therapies: Invention or Innovation?
  • Liam Tremble
  • September 23, 2026
  • 7 min
  1. Cell therapies represent a significant advancement in synthetic biology, offering potential cures for late-stage cancers and various diseases.
  2. Healthcare systems face challenges in delivering advanced therapies due to varying infrastructure and resource availability across regions.
  3. Efforts are underway to broaden access to cell therapies in community settings, but significant barriers remain in education and resource allocation.
  4. Emerging therapies like bispecific antibodies present severe toxicities, necessitating new skillsets among healthcare providers for effective management.
  5. Regulatory and investment challenges hinder the development of supportive care drugs, impacting the management of treatment-related toxicities.
...more

Eye

  • September 23, 2026
Adverse Events Associated with the Adjustability of Light-Adjustable Lenses
  • Sam T. C. Leung
  • Vanissa W. S. Chow
  • Julia Y. Y. Chan
  • September 23, 2026
  1. The light-adjustable lens (LAL) allows non-invasive postoperative modification of IOL power by up to 3 Dioptres.
  2. Postoperative adherence to UV protection is critical to prevent unintended premature photopolymerisation of the LAL.
  3. Noncompliance with UV protection can lead to reduced visual acuity and visual disturbances, necessitating lens exchange.
  4. Reports indicate refractive dissatisfaction and visual disturbances can occur after the final lock-in treatment of the LAL.
  5. Optics-related adverse events from the LAL may be irreversible and could require lens explantation.
...more

Jama Network Open

  • September 23, 2026
Impact of Probiotics on Mortality, Necrotizing Enterocolitis, and Sepsis in Extremely Preterm Infants
  • Ayoub Mitha
  • Sofia Söderquist Kruth
  • Emma Sinervo
  • Magnus Domellöf
  • Björn Brindefalk
  • Thomas Abrahamsson
  • Stefan Johansson
  • Alexander Rakow
  • September 23, 2026

Objective: To assess the associations of probiotic supplementation with death, necrotizing enterocolitis (NEC), and sepsis in extremely preterm infants. Approac

...more

United States Department Of Health And Human Services

  • September 23, 2026
HHS Invites Public Feedback on Enhancing Access to Islet Cell Treatments from Deceased Donors
  • Assistant Secretary for Public Affairs (ASPA)
  • September 23, 2026

Objective: To gather public input on the regulation of deceased-donor islet cells and related cellular products for treating type 1 diabetes. Approach: Regulato

...more

Jama Network Open

  • September 23, 2026
Impact of Custom Alert Settings in Continuous Glucose Monitoring on Glycemic Management in Diabetic Patients
  • Yaguang Zheng
  • Stephen B. Johnson
  • Eduardo Iturrate
  • Bei Wu
  • Heng Huang
  • William Small
  • Susan Zweig
  • Rozalina G. McCoy
  • September 23, 2026
  1. Continuous glucose monitoring (CGM) is standard care for type 1 and insulin-treated type 2 diabetes, improving glycemic management.
  2. The study analyzed data from 2387 patients using Dexcom G6 CGM, with a mean age of 42.7 years and a majority having type 2 diabetes.
  3. Activation of low-glucose alerts was linked to reduced time below range but increased time above range, indicating mixed effects.
  4. High-alert activation was associated with lower average glucose and higher time in range, particularly in patients with type 1 diabetes.
  5. The study highlights the need for further research on individualized CGM alert settings and their impact on glycemic outcomes.
...more

Nature Cancer

  • September 23, 2026
Innovative Approaches in Cancer Treatment
  • September 23, 2026
  1. Surgery, chemotherapy, and radiotherapy have been foundational in cancer therapy, but new modalities like immunotherapies are emerging.
  2. Immunotherapy, including immune checkpoint inhibitors, shows promise but faces challenges like varying response rates and treatment resistance.
  3. CAR-T cell therapies have transformed hematological cancer management, yet their efficacy in solid tumors and manufacturing costs remain barriers.
  4. Engineered oncolytic viruses and bacteria are being explored as cancer therapeutics, but clinical translation faces significant obstacles.
  5. Targeted therapies have evolved, with PARP inhibitors and KRAS inhibitors demonstrating advances, while antibody-drug conjugates face emerging resistance.
...more